Cocrystal Pharma Inc (COCP) support and resistance · rev $105.0K
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
This page maps Cocrystal Pharma Inc (COCP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
COCP currently screens at market cap $13.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new COCP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the COCP quote page for the session range and the stock page for the full model.
Not investment advice.